Amr M. Fahmi: Genotype-Guided Warfarin Dosing in the Arab Population
Amr M. Fahmi, Clinical Pharmacist at Hamad Medical Corporation, Adjunct Clinical Instructor at Qatar University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical and Applied Thrombosis/Hemostasis, adding:
“I am delighted to share our publication where we derived and validated a genotype guided warfarin dosing algorithm in the Arab population.
With a sample of more than 400 patients, the new algorithm had better precision compared to Gage et Al. in the studied population.”
Title: Derivation and Validation of a Genotype – Guided Warfarin Dosing Model in a Mixed Arab Population
Authors: Amr M Fahmi, Ahmed El Bardissy, Mohamed Omar Saad, Islam Eljilany, Loulia Bader, Hazem Elewa
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 04:23Barbara Adams Krolak: Women and Blood Clots Are We Missing the Warning Signs
-
Oct 8, 2026, 04:10Rutendo Muzambi: Hospital Admission Patterns and Care Disparities in Sickle Cell Disease
-
Oct 8, 2026, 03:50Olfat Berro: Redefining the Future of Haemophilia A
-
Oct 8, 2026, 03:35Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target